Statins increase risk of diabetes in Caucasian men
the ONA take:
According to new research published in the journal Diabetologia, researchers from Finland have found that statin use is associated with an increased risk of developing diabetes.
In the study, researchers analyzed data from 8,749 non-diabetic men in a 6-year follow-up of the population-based Metabolic Syndrome in Men (METSIM) study in Finland.
The participants ranged in age from 45 to 73 years and were followed for 5.9 years. Of those men, 625 were diagnosed with new diabetes during the follow-up period.
Results showed that after adjusting for confounding factors, patients treated with statins were 46% more likely to develop diabetes compared with those non treated with statins. In addition, researchers found that the risk was dose-dependent for atorvastatin and simvastatin.
The authors suggest that the association between statin use and increased risk for diabetes is most likely due to statins decreasing both insulin sensitivity and insulin secretion.
Although the findings are reliable, the study only included Caucasian men and therefore should not be applied to women or people of other ethnic origin without further research.
Statin use is associated with an increased risk of developing diabetes.
Sign Up for Free e-newsletters
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- Aggressive Therapy Provides No Additional Advantage in Metastatic Prostate Cancer
- Excretion of Volatile Organic Compounds Higher in AYAs Using Vaping Products
- FDA, ASHP Actions to Prevent or Manage Chemotherapy Drug Shortages
- Breast Cancer Screening Recommendations Not Completely Reflective of Race, Age
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Sexual Quality of Life Decreased During, After Chemotherapy for Digestive Cancers
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Approach and Management of Checkpoint Inhibitor-related Immune Hepatitis
- Revised AJCC8 Demonstrates Superior Tumor Classification for HNCSCC
- Oral Androgen Receptor Inhibitor Granted FDA Approval for Nonmetastatic CRPC
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|